At Q2 2025, U.S. GDP stood at around $30.5 trillion, and one wants to keep in mind at this point that mega-caps representing ...

MetaVista3D, Inc. ( ($TSE:DDD) ) has issued an announcement. Metavista3D Inc. announced its participation in the Emerging Growth Conference on ...

Google's Android XR developer kits and XReal's Project Aura point toward a future where smart glasses move beyond novelty and ...

Utilizing a >400 RFU threshold, treatment with leronlimab was associated with the upregulation of PD-L1 in CTCs and cancer-associated macrophage-like cells (CAMLs) in 76% (n=16/21) of patients overall ...

The AI widgets taking over news sites and extracting our data. Sign up for the daily CJR newsletter. Recently, on the website of USA Today, I asked a generative AI chatbot called DeeperDive a question ...

DoubleVerify Holdings, Inc. ( DV) Raymond James TMT & Consumer Conference December 8, 2025 10:00 AM EST ...

This Tesla’s New Era review 2025 breaks down Rob Spivey’s claims, the robotics opportunity, and what you get with Hidden Alpha to see if his prediction is accurate.

Snowflake, Inc. reported strong adjusted free cash flow and FCF margins for its Q3 ended Oct. 31. Moreover, management ...

Progression free survival (PFS) of 74% at 16 months compares favourably to standard of care PFS of 50% at 11.5 months 1 Strong PFS consistent across key subgroups Reaffirms selection of iSCIB1+ and ...

When you click on “Accept all”, you consent to ads on this site being customized to a personal profile we or our advertising ...

Presentation Title: The ADELA study: A Double-blind, Placebo-controlled, Randomized Phase 3 Trial of Elacestrant (ELA)+ Everolimus (EVE) Versus ELA + Placebo (PBO) in ER+/HER2-Advanced Breast Cancer ...

The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, ...